CN113069473B - Plaster prepared from medicinal residues for refreshment - Google Patents

Plaster prepared from medicinal residues for refreshment Download PDF

Info

Publication number
CN113069473B
CN113069473B CN202110447157.9A CN202110447157A CN113069473B CN 113069473 B CN113069473 B CN 113069473B CN 202110447157 A CN202110447157 A CN 202110447157A CN 113069473 B CN113069473 B CN 113069473B
Authority
CN
China
Prior art keywords
musk
dregs
fine powder
residue
xingnaojing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110447157.9A
Other languages
Chinese (zh)
Other versions
CN113069473A (en
Inventor
毛菊红
朱音
王晓霞
过晓磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi Jiyu Shanhe Pharmaceutical Co ltd
Original Assignee
Wuxi Jiyu Shanhe Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Jiyu Shanhe Pharmaceutical Co ltd filed Critical Wuxi Jiyu Shanhe Pharmaceutical Co ltd
Priority to CN202110447157.9A priority Critical patent/CN113069473B/en
Publication of CN113069473A publication Critical patent/CN113069473A/en
Application granted granted Critical
Publication of CN113069473B publication Critical patent/CN113069473B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/241—Lead; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A61K36/515—Gentiana
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a plaster prepared from Xingnaojing dregs, wherein the Xingnaojing dregs are musk dregs fine powder obtained by drying, grinding and sieving extracted musk after preparing Xingnaojing, and the musk dregs fine powder is mixed with other medicines to prepare external preparations for skin diseases, joint diseases and the like; the invention provides a traditional Chinese medicine external preparation for activating blood circulation to promote menstruation and relieving swelling and pain, which is prepared from musk residue fine powder, and traditional Chinese medicine raw materials such as papaya, large-leaf gentian root, stephania tetrandra, lycopodium clavatum, angelica dahurica, kudzuvine root, red lead powder and the like.

Description

Plaster prepared from medicinal residues for refreshment
Technical Field
The invention relates to the field of medicines, relates to application of Xingnaojing medicine residues, and in particular relates to application of musk medicine residues in the Xingnaojing medicine residues.
Background
The Xingnaojing injection is a Chinese medicinal injection prepared from musk, borneol, radix curcumae and gardenia by steam distillation and refining, and has the effects of clearing away heat and toxic materials, cooling blood, activating blood circulation, inducing resuscitation and restoring consciousness. The product is prepared by preparing a Chinese medicinal name Fang Angong bezoar pill, wherein the dosage of musk in the prescription is 7.5g, musk is distilled and extracted from liquid medicine in the preparation process of Xingnaojing injection, and the musk is detected to have about 50% of musk ketone (active ingredient) in the finished product.
Musk is dry secretion in deer forest musk or Ma She or raw musk mature male sachet, is a rare Chinese medicinal material, has the effects of inducing resuscitation and refreshing mind, promoting blood circulation and dredging channels, and relieving swelling and pain, and is clinically used for treating febrile diseases and unconsciousness, apoplexy and phlegm syncope, traumatic injury pain, arthralgia and numbness, carbuncle and swelling scrofula and the like.
The Xingnaojing injection is prepared from the following Chinese medicinal components by extraction, wherein musk is extracted and processed independently, and the extraction and processing method is as follows: adding Moschus into distillate of fructus Gardeniae and radix Curcumae, soaking for 1 hr, and distilling. The residue obtained after extraction is usually treated as solid waste.
The inventor detects musk dregs, takes musk ketone as a main index, compares the musk ketone total amount with the musk ketone total amount of the raw medicinal material after musk distillation extraction by measurement, and calculates the transfer rate to be about 50%, namely, the effective components still remain about 50% in the dregs. Since musk is valuable, the residue of musk can be reused, which is beneficial to human beings.
The inventor prepares the Xingnaojing, then dries and grinds the extracted musk, and passes through a 100-mesh sieve to obtain musk dreg fine powder (yellowish brown powder). The inventor mixes the musk dreg fine powder with other medicines to prepare external preparations for skin diseases, joint diseases and the like, and obtains unexpected technical effects.
The external preparation which can be prepared by the invention comprises the following components: the musk pain-dispelling aerosol, musk pain-dispelling liniment, musk traumatic injury rheumatism ointment, musk Shu Huocha and the like.
Preferably, the external preparation is used for treating arthralgia-syndrome such as rheumatism and rheumatoid arthritis, and the clinical manifestations of the diseases are pain, soreness, heavy attachment of bones and muscles of limbs, and even difficulty in flexion and extension, swelling and deformation of joints. The pathogenic factors are that pathogenic factors such as wind, cold, dampness and heat block the channels and collaterals, and the qi and blood operation is affected. Musk has the effects of activating blood and dredging channels, and relieving swelling and pain. The musk residue fine powder is prepared by processing the extracted musk residue, so that the resource is reused, the maximum development and utilization of the resource are realized, the solid waste processing cost of enterprises is reduced, and the environmental pollution hazard is reduced.
Disclosure of Invention
The invention provides an application of musk extracted residues (called musk residue fine powder).
The invention preferably provides a traditional Chinese medicine preparation using musk dregs fine powder as raw materials.
More preferably, the present invention is characterized in that the residue after musk extraction (called musk residue fine powder) is used as a raw material of the external preparation for Chinese medicine of the present invention.
The invention provides a traditional Chinese medicine external preparation for activating blood circulation to promote menstruation and relieving swelling and pain, which is prepared from musk residue fine powder, and traditional Chinese medicine raw materials such as papaya, large-leaf gentian root, stephania tetrandra, lycopodium clavatum, angelica dahurica, kudzuvine root, red lead powder and the like.
The weight ratio of each component is as follows:
the most preferred weight proportions of the components are as follows:
the invention further provides a preparation method of the traditional Chinese medicine external preparation, which comprises the following steps:
(1) Drying Moschus residue at low temperature, and grinding into powder.
(2) Placing 5-10 g of papaya, 5-10 g of gentiana macrophylla, 4-8 g of stephania tetrandra, 4-8 g of lycopodium clavatum, 4-8 g of angelica dahurica and 4-8 g of kudzuvine root into hot oil after vegetable oil or animal oil is slightly heated in a pot, heating and continuously stirring until the materials are fried until the surface is dark brown and the interior is brown. After frying, the medicine oil is obtained for standby by hot filtration.
(3) Continuously decocting the above medicinal oil until the medicinal oil can be dripped into beads (the medicinal oil is dripped into water to form beads);
(4) After the medicinal oil is refined, adding Plumbum Preparatium powder (traditional Chinese medicine Plumbum Preparatium powder, also called Plumbum Preparatium powder, plumbum Preparatium can directly kill bacteria and parasites and has effect of stopping mucus secretion) under stirring, spraying clear water, and soaking in clear water.
(5) Taking out the plaster, placing in a pot, heating with small fire to melt, scattering 0.1-0.5 g of musk dregs powder, and stirring uniformly.
(6) And (3) a proper amount of plaster is taken to be coated on plaster cloth, sheared and packaged.
The method is obtained through screening, and the screening process is as follows:
1. proportion selection
The plaster prepared by the proportions has good plaster forming effect, moderate viscosity and softening point of 43-55 ℃.
2. Plaster for use
After the plaster preparation was completed, 42 people used the 4 formulations. The people who use the medicine are all suffering from rheumatism and rheumatoid diseases for a long time, and the pain of the affected part is aggravated in overcast and rainy weather. The plaster is applied to the affected part for about 2 weeks.
Sample of Number of people used Effective and effective Wherein the effect is displayed Invalidation of Adverse reactions
Proportion 1 10 times 7 times of people 3 times of people 3 times of people 1 case of the patch has rash
Proportion 2 9 times of people 7 times of people 5 times of people 2 times of people Without any means for
Proportion 3 11 times of people 11 times of people 7 times of people 0 times of Without any means for
Proportion 4 12 times 11 times of people 6 times 1 person times Itching was found in 2 cases of patches
The product is used by 42 persons for times, the effectiveness is more than 85%, and part of patients have anaphylactic phenomena such as rash, pruritus and other adverse reactions, and the product is improved once stopping taking the medicine.
The plaster prescription belongs to the first creation of the invention. The musk in the formula has the effects of activating blood, dredging channels, reducing swelling and relieving pain; papaya, gentiana macrophylla, lycopodium clavatum, stephania tetrandra and papaya are all wind-damp dispelling medicines, and have the effects of relaxing tendons and activating collaterals, dispelling wind and removing dampness, wherein lycopodium clavatum also has the effects of activating blood and relieving swelling, and stephania tetrandra has the effects of relieving pain and promoting diuresis. Radix Angelicae Dahuricae and radix Puerariae belong to the meridian-inducing medicine for yangming meridian, and radix Puerariae also has effects of relieving muscle and reducing fever. The eight medicinal materials together play the roles of dispelling wind, removing dampness, relieving dysmenorrheal and pain.
The invention has the following creative work:
(1) The musk waste residue is reused in the production process of the Xingnaojing injection preparation for the first time, so that musk resources are saved, the solid waste treatment cost of enterprises is reduced, and energy conservation and environmental protection are realized.
(2) The self-made plaster has simple technological operation and good clinical effect.
Detailed Description
The invention is further illustrated, but not limited, by the following specific examples.
Example 1:
(1) Drying Moschus residue at low temperature, and grinding into powder.
(2) After 500 g of lard is put into a pot to be slightly heated, 50 g of papaya, 40 g of gentiana macrophylla, 40 g of stephania tetrandra, 40 g of lycopodium clavatum, 40 g of angelica dahurica and 40 g of kudzuvine root are put into hot oil, and the mixture is heated and stirred continuously until the mixture is fried to the deep brown surface and the internal brown surface. After frying, the medicine oil is obtained for standby by hot filtration.
(3) Decocting the above medicinal oil until the medicinal oil can be dripped into beads.
(4) After the medicinal oil is refined, 215 g of red lead powder is added while stirring until paste is viscous, clear water is sprayed, and the paste is formed into lumps and is soaked in the clear water.
(5) Taking out the plaster, placing in a pot, heating with small fire to melt, scattering 1 g of musk dregs powder, and stirring uniformly.
(6) 20 g of plaster is uniformly coated on plaster cloth (12 cm. Times.10 cm) to be used.
Example 2:
(1) Drying Moschus residue at low temperature, and grinding into powder.
(2) After 500 g of lard is put into a pot to be slightly heated, 90 g of papaya, 90 g of gentiana macrophylla, 60 g of stephania tetrandra, 60 g of lycopodium clavatum, 60 g of angelica dahurica and 60 g of kudzuvine root are put into hot oil, and the mixture is heated and stirred continuously until the mixture is fried to the deep brown surface and the internal brown surface. After frying, the medicine oil is obtained for standby by hot filtration.
(3) Decocting the above medicinal oil until the medicinal oil can be dripped into beads.
(4) After the medicinal oil is refined, 240 g of red lead powder is added while stirring until the paste is viscous, clear water is sprayed, and the paste is formed into a lump and is soaked in the clear water.
(5) Taking out the plaster, placing in a pot, heating with small fire to melt, scattering 5g of musk dregs powder, and stirring uniformly.
(6) 20 g of plaster is uniformly coated on plaster cloth (12 cm. Times.10 cm) to be used.
Example 3:
(1) Drying Moschus residue at low temperature, and grinding into powder.
(2) Putting 500 g of peanut oil into a pot to slightly heat, and then putting 90 g of papaya, 90 g of gentiana macrophylla, 60 g of stephania tetrandra, 60 g of lycopodium clavatum, 60 g of angelica dahurica and 60 g of kudzuvine root into hot oil, heating and continuously stirring until the materials are fried to the deep brown surface and the internal brown. After frying, the medicine oil is obtained for standby by hot filtration.
(3) Decocting the above medicinal oil until the medicinal oil can be dripped into beads.
(4) After the medicinal oil is refined, 235 g of red lead powder is added while stirring until the paste is viscous, clear water is sprayed, and the paste is formed into a lump and is soaked in the clear water.
(5) Taking out the plaster, placing in a pot, heating with small fire to melt, scattering 5g of musk dregs powder, and stirring uniformly.
(6) 20 g of plaster is uniformly coated on plaster cloth (12 cm. Times.10 cm) to be used.

Claims (1)

1. An external plaster for treating rheumatism or rheumatoid disease, which is characterized by being prepared from the following raw materials in parts by weight:
9 g of papaya, 9 g of gentiana macrophylla, 6 g of stephania tetrandra, 6 g of lycopodium clavatum, 6 g of angelica dahurica, 6 g of kudzuvine root, 0.1 g of musk residue fine powder and 25 g of red lead powder;
the preparation method of the musk dreg fine powder comprises the following steps:
adding Moschus into water vapor distillate of fructus Gardeniae and radix Curcumae, soaking for 1 hr, distilling, extracting to obtain residue, drying the residue at low temperature, and grinding.
CN202110447157.9A 2021-04-24 2021-04-24 Plaster prepared from medicinal residues for refreshment Active CN113069473B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110447157.9A CN113069473B (en) 2021-04-24 2021-04-24 Plaster prepared from medicinal residues for refreshment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110447157.9A CN113069473B (en) 2021-04-24 2021-04-24 Plaster prepared from medicinal residues for refreshment

Publications (2)

Publication Number Publication Date
CN113069473A CN113069473A (en) 2021-07-06
CN113069473B true CN113069473B (en) 2023-08-11

Family

ID=76618631

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110447157.9A Active CN113069473B (en) 2021-04-24 2021-04-24 Plaster prepared from medicinal residues for refreshment

Country Status (1)

Country Link
CN (1) CN113069473B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102363016A (en) * 2011-10-26 2012-02-29 无锡济民可信山禾药业股份有限公司 Traditional Chinese medicine composite dripping core pills and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102363016A (en) * 2011-10-26 2012-02-29 无锡济民可信山禾药业股份有限公司 Traditional Chinese medicine composite dripping core pills and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
【名人百科】屈辱哀怨的一生——清德宗光绪;苍狼剑;《https://new.qq.com/rain/a/20201013A082QC》;20201019;第1-2页，尤其是第2页第3段 *

Also Published As

Publication number Publication date
CN113069473A (en) 2021-07-06

Similar Documents

Publication Publication Date Title
CN108578497A (en) It is a kind of to be used to treat external application hot compress magnetic moxibustion mud of human body pain and preparation method thereof
CN103735765B (en) Plaster for activating collaterals and relieving pain and preparation method thereof
CN105125795A (en) Plaster for treating traumatic injuries and capable of reuniting fractured bones and tendons and preparation method of plaster
CN113069473B (en) Plaster prepared from medicinal residues for refreshment
CN1314441C (en) Plaster for relaxing the muscles and joints and its prepn process
CN107510820B (en) Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain and preparation method thereof
CN101953919B (en) Alligator oil scald-burn cream and preparation method thereof
CN102302752A (en) Traumatic injury plaster
CN109395018A (en) A kind of one moxibustion health-care paste of moxibustion of human body external application is manufactured and its application method
CN101406591B (en) Plaster for treating sore, carbuncle and painful swelling and preparation method thereof
CN108159386A (en) A kind of plaster and preparation method thereof
CN103860946A (en) External ointment for treating injuries from falls and preparation method thereof
CN108096384A (en) It removes obstruction in channels to relieve pain tincture and preparation method thereof
CN103893347A (en) Traditional Chinese medicine composition for treating cutaneous pruritus
CN110496209A (en) A kind of black mud cream of human body external application is manufactured and its application method
CN102670347B (en) Production method of hot compress paste of attapulgite, distillers' grains and mugwort leaves
CN1049826C (en) "Biantianfengshiqing" medicine for treating rheumatism
CN110575460A (en) external patch for improving immunity and preparation method thereof
CN103877557B (en) A kind of Chinese medicine ointment and preparation method for the treatment of tinea unguium
CN109432211A (en) For the Chinese medicine composition and its external drug of psoriasis and eczema and the preparation method and application of the two
CN102670391B (en) Hot compress paste of attapulgite, distillers' grains and mugwort leaves
CN102552552B (en) Traumatic injury plaster and preparation method thereof
CN106176437A (en) A kind of quickly anti-acne smears gel and preparation method thereof
CN105709194A (en) Traditional Chinese medicine composition for treating stroke and external preparation thereof and preparation method of external preparation
CN105796796A (en) External plaster for promoting blood circulation to remove blood stasis and manufacturing method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant